In this study, TGF-β1 increased the phosphorylation of Smad2/3 and ERK in primary fibroblasts from patients with IPF, and treatment with 11,12-EET and TPPU suppressed these effects (Fig. 4a, b). Here, SMAD2 is linked to idiopathic pulmonary fibrosis.